- Date: July 06, 2017
Two examples of the 23 projects that will be participating in the 2017 edition of CaixaImpulse are an easy-to-use lower limb exoskeleton to improve walking recovery for patients with spinal cord injuries (ABLE project) and a non-invasive technology to map cardiac arrhythmias and help choose the best treatment options (CORIFY project).
The projects were presented by their respective leaders during a press conference held on 5 July at the Palau Macaya, in Barcelona. The presentation was chaired by Jaume Giró, managing director of “la Caixa” Banking Foundation, and Marcelino Armenter, managing director of CriteriaCaixa and chairman of Caixa Capital Risc.
Giró detailed some of the news related to this year’s edition, such as the programme being extended to Portugal. In fact, one of the seven projects presented from Portugal has been selected. Led by researchers from the University of Coimbra, Biolocker is an oral care solution to prevent dental plaque from forming.
The second item of news is the participation of EIT Health, a leading European consortium in biomedicine innovation. According to Giró, the consortium contribute €210,000, which “has allowed us to increase the number of participating projects by three, in comparison to 2016”.
Armenter explained that CaixaImpulse offers support to help research transfer to the market, a process that is far from easy, “We help research projects on their way to the market, so that they can succeed and benefit society with their innovations.”
The call for proposals for the 2017 programme received a total of 80 proposals, 11% more than last year. So far, CaixaImpulse has spent 5.5 million euros and has promoted 58 initiatives, two of which have already become spin-offs, with five more in the process.
More programme highlights
June 11, 2019
This is the second part of our two-part interview with technology transfer expert, Esther Riambau, Life Sciences Director at UPF Ventures.
June 04, 2019
This is the first part of our two-part interview with technology transfer expert, Esther Riambau, Life Sciences Director at UPF Ventures.
May 29, 2019
Two years on from its participation in CaixaImpulse, we caught up with Aortyx CEO Jordi Martorell, who talked us through the project’s development and its key objectives for the future.